Prostate Cancer

Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Prostate Cancer

Prostate cancer is one of the most common cancers in men, with more than 40,000 new cases diagnosed every year in the UK. This is usually a slow growing cancer and most men do not notice the symptoms until the cancer has become large enough to press against the urethra and interfere with urination.

Precancerous conditions of the prostate

What is the Gleason Score?

Prostate Cancer Symptoms

Survival rates of prostate cancer

What is Prostatectomy?

What is benign prostatic hyperplasia?

Prostate Cancer and Exercise

Vasectomy and prostate cancer: Myth or reality?

Prostate Cancer Diagnosis

Recent Genetic Breakthroughs in Prostate Cancer Research

Choosing the best treatment of prostate cancer - by stage

See more featured articles »

Prostatitis symptoms

PSA False Positive and False Negative Results

Prostate cancer complications

Breakthroughs in Prostate Cancer Treatments

Cryosurgery for prostate cancer

Prostate Cancer and Genetics

Should MRI be Used to Diagnose Prostate Cancer?

Prostate Cancer and Diet

Prostate Cancer Epidemiology

Gallium Ga 68-labeled PSMA-11 PET/CT Imaging for Prostate Cancer

Treatment of prostatitis

Symptoms of Benign Prostatic Hyperplasia (BHP)

Differentiating between prostate cancer and prostate enlargement

Prostate cancer alternative and complementary therapies

Prostate Cancer Questions

Diagnosis of Benign Prostatic Hyperplasia (BPH)

Diagnosis of prostatitis

What Should You Avoid Before a PSA Test?

What is the PSA Test?

Hormonal therapy for prostate cancer

Treatment of Benign Prostatic Hyperplasia (BHP)

Causes of prostatitis

Brachytherapy for Prostate Cancer

Radiation therapy for prostate cancer

Palliative treatment and end of life care for prostate cancer

Prostate Biopsy

Prostate Cancer Screening

Types of PSA Test

Prostate Cancer Partin Tables

Prostate Cancer Epidemiology Worldwide

Causes of benign prostatic hyperplasia

Prostate Cancer Research

The International Prostate Symptoms Score (IPSS)

What is the PCA3 Test?

Prostate Cancer Staging

PSA Test in Men Who Have Been Treated for Prostate Cancer

The Prostate

Prostate cancer prevention

Single Nucleotide Polymorphisms and Prostate Cancer

What is TURP?

Prostate Cancer Treatment

Prostate Cancer Cell Dormancy and Activation

Rectal Examination for Prostate Cancer

What is medical castration?

What is Prostatitis?

Gold Nanoparticles Use in Prostate Cancer

Prostate Cancer Risk Factors

Life after prostate cancer treatment

Can Curcumin Prevent or Treat Prostate Cancer?

Latest Prostate Cancer News and Research

Rethinking prostate cancer risk in GG1 diagnoses

A new study reveals that some men who are diagnosed with "Grade Group one" (GG1) prostate cancer may actually be at higher risk than biopsy results suggest, according to research led by Weill Cornell Medicine, University Hospitals Cleveland and Case Western University.

31 Jul 2025

Most dairy foods linked to neutral or better health but yogurt stands out for real benefits

A major scoping review of recent systematic reviews and meta-analyses finds that most dairy products are either neutral or modestly protective for heart, cancer, metabolic, and mortality outcomes in adults. Yogurt and other fermented dairy consistently show the strongest health associations, while some risks remain for specific cancers.

28 Jul 2025

AI tool predicts tumor aggressiveness using protein markers

As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances in diagnosis and treatment.

15 Jul 2025

Acromegaly linked to higher cancer risk

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, according to a study being presented Monday at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.

15 Jul 2025

Guideline-based prostate cancer treatment helps most men outlive the disease

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of these men will die of causes other than prostate cancer.

14 Jul 2025

Prostate cancer cells evade ferroptosis by accumulating lipid droplets

A new research paper was published in Volume 16 of Oncotarget on June 25, 2025, titled "Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer."

14 Jul 2025

Study confirms high survival rates for men with low-risk prostate cancer

New research in the July 2025 issue of JNCCN-Journal of the National Comprehensive Cancer Network finds that for people diagnosed with nonmetastatic low-risk prostate cancer later in life, and treated according to NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines), 90% were likely to survive their cancer for their remaining life-expectancy.

11 Jul 2025

World’s premier cancer institute faces crippling cuts and chaos

The Trump administration's broadsides against scientific research have caused unprecedented upheaval at the National Cancer Institute, the storied federal government research hub that has spearheaded advances against the disease for decades.

9 Jul 2025

Coffee ring effect inspires breakthrough in rapid at-home tests for disease detection

Got a sore throat and the sniffles? The recent rise of rapid at-home tests has made it easier to find out if you have a serious illness like COVID-19 or just a touch of spring allergies.

8 Jul 2025

Study identifies why some prostate cancers fail to respond to treatment

A new study from University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.

8 Jul 2025

Blocking key immune cells could make prostate cancer treatable

Scientists have revealed how certain immune cells may be quietly helping prostate cancer grow - and how blocking them could help the body fight back.

3 Jul 2025

In a first, Trump and GOP-led Congress prepare to swell ranks of U.S. uninsured

Last September, Alton Fry went to the doctor concerned he had high blood pressure. The trip would result in a prostate cancer diagnosis.

30 Jun 2025

Study reveals how FOXA1 mutations drive prostate cancer and therapy resistance

A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct classes of mutations in the FOXA1 gene-commonly altered in prostate cancer-drive tumor initiation formation and therapeutic resistance.

26 Jun 2025

Harnessing saliva for precision medicine and early disease diagnosis

A research team led by the University of the Basque Country (Euskal Herriko Unibertsitatea, EHU) has identified hundreds of molecular markers in saliva that could reveal the risk of a person developing major diseases such as cancer, cardiovascular diseases, diabetes and neurodegenerative diseases.

26 Jun 2025

Dual threats from Trump and GOP imperil nursing homes and their foreign-born workers

In a top-rated nursing home in Alexandria, Virginia, the Rev. Donald Goodness is cared for by nurses and aides from various parts of Africa.

26 Jun 2025

Fusion genes found to be pivotal players in cancer development

Fusion genes, arising from abnormal chromosomal rearrangements, are gaining recognition as pivotal players in cancer development. These genetic alterations result in the creation of hybrid genes with altered functions, often driving tumor progression.

25 Jun 2025

Uncovering hidden disease clues with nanoparticles and AI

Imagine Spartan Stadium packed with 75,000 fans, all wearing green and white jerseys - except one person in a solid green shirt.

24 Jun 2025

New DNA test predicts chemotherapy resistance in cancer patients

Cancer Research UK-funded scientists at the University of Cambridge, in collaboration with the Spanish National Cancer Research Centre (CNIO) and Cambridge-based startup Tailor Bio, have created a test which can successfully predict whether cancer will resist common forms of chemotherapy treatment.

23 Jun 2025

Inflammation drives early prostate cancer through cellular reprogramming

Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer formation are poorly understood.

23 Jun 2025

TTUHSC researchers seek to understand TBX2's role in bone metastasis of prostate cancer

The American Cancer Society estimates that more than 313,780 cases of prostate cancer will be diagnosed in the United States in 2025, resulting in approximately 35,770 deaths.

12 Jun 2025